https://www.oncobites.tv/vnl-mama/c%C3%A1ncer-de-mama-er-low-y-hormonoterapia-adyuvante 2026-04-13 https://www.oncobites.tv/vnl-mama/opciones-terap%C3%A9uticas-para-c%C3%A1cner-de-mama-rh%2B-her2---tras-progresi%C3%B3n-con-inhibidores-de-cdk4%2F6 2026-04-13 https://www.oncobites.tv/vnl-mama/los-biomarcadores-actuales-y-emergentes-definen-el-tratamiento-del-c%C3%A1ncer-de-mama-avanzado 2026-04-13 https://www.oncobites.tv/vnl-mama/un-abanico-de-posibilidades-terap%C3%A9uticas-en-c%C3%A1ncer-de-mama-her2%2B 2026-04-13 https://www.oncobites.tv/vnl-mama/los-adcs-est%C3%A1n-transformado-el-tratamiento-del-c%C3%A1ncer-de-mama-luminal 2026-04-13 https://www.oncobites.tv/vnl-mama/triple-negativo-adyuvancia%3A-%C2%BFinmunoterapia-para-todas%3F 2026-04-13 https://www.oncobites.tv/vnl-mama/ctdna-como-herramienta-predictora-y-pron%C3%B3stica-de-reca%C3%ADda-en-c%C3%A1ncer-de-mama-luminal-estadio-precoz 2026-04-13 https://www.oncobites.tv/vnl-mama/terapia-adyuvante-del-c%C3%A1ncer-de-mama-rh%2B%2Fher2%E2%80%93-con-cdk4%2F6 2026-04-13